SEC Form 4 · accession 0001437749-26-022511
BIO KEY INTERNATIONAL INC · BKYI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mira K Lacous
Officer — Chief Technology Officer
Period of report
Jun 30, 2026
Accepted (ET)
Jul 2, 2026 · 4:16 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001019034
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jun 30, 2026 | A | 250 | $3.83 | A | 4,076 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares acquired under the BIO-key International, Inc. 2021 Employee Stock Purchase Plan as amended in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- F2All share amounts reflect BIO-key's 1-for-10 reverse stock split, which was effective April 30, 2026.